Origin Therapeutics Holdings Inc.

DB:U8B Voorraadrapport

Marktkapitalisatie: €979.2k

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Origin Therapeutics Holdings Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Michael Galego

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEO1.0%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates


CEO

Michael Galego (44 yo)

less than a year

Tenure

Mr. Michael Galego Serves as Interim CEO of Origin Therapeutics Holdings Inc. Since January 14, 2023. He serves as Director at Origin Therapeutics Holdings Inc. since September 2022. He has been an Observe...